Revenue Growth Driven by Increased Sales
PG's revenue increased by 7.4% year-over-year to $21.24 billion, primarily due to higher sales volumes across key product segments.
Source: 10-Q Income Statement
Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
PG reported solid revenue growth of 7.4% in Q3 FY2026, driven by increased sales, despite facing rising costs that slightly pressured margins.
Revenue
$21.23B
+7.38% YoY
EPS (Diluted)
$1.63
+5.84% YoY
Operating Income
$4.58B
+0.39% YoY
Source: SEC XBRL
Procter & Gamble (PG) reported Q3 FY2026 revenue of $21.23B, up 7.4% year over year. Operating margin was 21.5%, down 1.5 points from 23.0% a year earlier. PG's fiscal Q3 FY2026 corresponds to calendar Q1 2026.
Last 4 quarters: 1 beat
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | 1.43 | 1.45 | Miss -1.5% |
| Mar 2026This filing | 1.59 | 1.60 | Miss -0.8% |
| Dec 2025 | 1.88 | 1.91 | Miss -1.6% |
| Sep 2025 | 1.99 | 1.95 | Beat +1.9% |
Adjusted (non-GAAP) EPS of $1.59 versus the $1.60 analyst consensus — a -0.8% miss for Mar 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $1.63.
Compiled by AI from this SEC filing
PG's revenue increased by 7.4% year-over-year to $21.24 billion, primarily due to higher sales volumes across key product segments.
Source: 10-Q Income Statement
The cost of revenue rose by 10.6%, outpacing revenue growth and contributing to a slight decline in operating margin to 21.5%.
Source: 10-Q Income Statement
Operating cash flow increased by 12.4% year-to-date, reflecting efficient cash management and strong operational performance.
Source: 10-Q Cash Flow Statement
Compiled by AI from this SEC filing · 1 high, 1 medium, 1 low
The increase in cost of revenue by 10.6% indicates rising input costs, which could continue to pressure margins if not managed effectively.
Source: 10-Q Income Statement
With a current ratio of 0.73, PG faces potential liquidity challenges, as current liabilities exceed current assets.
Source: 10-Q Balance Sheet
A 28.4% reduction in share buybacks may signal a shift in capital allocation priorities, potentially affecting shareholder returns.
Source: 10-Q Cash Flow Statement
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue $B | 21.24 $B | 19.78 $B | +7.38% |
Cost of Revenue $B | 10.72 $B | 9.69 $B | +10.60% |
Operating Income $B | 4.58 $B | 4.56 $B | +0.39% |
Net Income $B | 3.93 $B | 3.77 $B | +4.32% |
EPS (Basic) $ | 1.66 $ | 1.58 $ | +5.06% |
EPS (Diluted) $ | 1.63 $ | 1.54 $ | +5.84% |
SG&A Expense $B | 5.94 $B | 5.52 $B | +7.46% |
Answers draw on this SEC filing and the data on this page
P&G reported flat organic volume growth and margin compression in FY2026, with operating income down 3% despite a 3% increase in reported net sales, as the company invested heavily in marketing and product superiority.
PG's Q2 FY2026 results show modest revenue growth but declining profitability due to increased costs and expenses.
Other companies in Personal Care Products